Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

NCT03197506 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Gliosarcoma
Supratentorial Glioblastoma

Interventions

RADIATION: External Beam Radiation Therapy
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
RADIATION: Radiation Therapy
DRUG: Temozolomide
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

Mayo Clinic